Get started
Author

Mikhail S. Dzeshka

Observed names: Dzeshka, Mikhail, Dzeshka, Mikhail S, M S Dzeshka, M. S. Dzeshka, M.S. Dzeshka, M.S. Dzeshka Dzeshka, Mikhail Dzeshka, Mikhail S Dzeshka
ORCID: 0000-0002-8446-5651
Observed ORCID: 0000-0002-8446-5651
OpenAlex ID: A5041986341
Cardiac Fibrosis in Patients With Atrial Fibrillation
2015 · Mikhail S. Dzeshka, Gregory Y.H. Lip, et al. · Journal of the American College of Cardiology · 564
PDF
Atrial Fibrillation and Hypertension
2017 · Mikhail S. Dzeshka, Alena Shantsila, et al. · Hypertension · 150
Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes
2017 · Mikhail S. Dzeshka, Farhan Shahid, et al. · American Journal of Hypertension · 93
Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk‐Score Acronyms (CHADS 2 , CHA 2 DS 2 ‐VASc, R 2 CHADS 2 , HAS‐BLED, ATRIA, and More)
2014 · Mikhail S. Dzeshka, Deirdre A. Lane, et al. · Clinical Cardiology · 60
Effects of Aspirin on Endothelial Function and Hypertension
2016 · Mikhail S. Dzeshka, Alena Shantsila, et al. · Current Hypertension Reports · 47
PDF
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation
2014 · Keitaro Senoo, Yee Cheng Lau, et al. · Circulation Journal · 39
PDF
Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?
2014 · Mikhail S. Dzeshka, Gregory Y.H. Lip · Trends in Cardiovascular Medicine · 21
Specific risk scores for specific purposes: Use CHA2DS2-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation
2014 · Mikhail S. Dzeshka, Gregory Y.H. Lip · Thrombosis Research · 14
Patients with atrial fibrillation undergoing percutaneous coronary intervention. Current concepts and concerns: part I
2015 · Mikhail S. Dzeshka, Richard A. Brown, et al. · Polskie Archiwum Medycyny Wewnętrznej · 12
PDF
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation
2016 · Mikhail S. Dzeshka, Gregory Y.H. Lip · Heart Failure Clinics · 11
Patients with atrial fibrillation undergoing percutaneous coronary intervention. Current concepts and concerns: part II
2014 · Mikhail S. Dzeshka, Richard A. Brown, et al. · Polskie Archiwum Medycyny Wewnętrznej · 11
PDF
Stroke And Bleeding Risk Assessment: Where Are We Now?
2014 · Mikhail S Dzeshka, Gregory Y H Lip · PubMed Central · 11
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation
2014 · Mikhail S. Dzeshka, Gregory Y.H. Lip · Cardiology Clinics · 10
Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation
2014 · Mikhail S Dzeshka, Gregory YH Lip · Expert Opinion on Drug Safety · 8
Percutaneous Coronary Interventions – Current State of Development: Stents Evolution
2020 · A. A. Chernyak, M. S. Dzeshka, et al. · Journal of the Grodno State Medical University · 5
PDF
Direct oral anticoagulant reversal: how, when and issues faced
2017 · Mikhail S. Dzeshka, Daniele Pastori, et al. · Expert Review of Hematology · 5
Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting
2016 · Mikhail S. Dzeshka, Richard A. Brown, et al. · Interventional Cardiology Clinics · 5
Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation
2015 · Mikhail S Dzeshka, Gregory YH Lip · Expert Opinion on Pharmacotherapy · 5
Percutaneous Coronary Interventions: Intravascular Imaging and Assessment of Intracoronary Haemodynamics
2020 · A. A. Chernyak, M. S. Dzeshka, et al. · Journal of the Grodno State Medical University · 4
P1720Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction
2017 · M.S. Dzeshka, K. Appadoo, et al. · European Heart Journal · 4
Prognostic Value of Hyperuricemia in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction
2015 · M.S. Dzeshka Dzeshka, V.A. Snezhitskiy Snezhitskiy, et al. · Kardiologiia · 3
Cardiovascular risk prediction: balancing complexity against simple practicality
2014 · Mikhail S Dzeshka, Paramjit S Gill, et al. · British Journal of General Practice · 3
PDF
Editorial commentary: Reversal agents in the era of non-vitamin k antagonists oral anticoagulants: Necessity or psychological crutch?
2019 · Mikhail S. Dzeshka, Gregory Y.H. Lip · Trends in Cardiovascular Medicine · 2
Editorial commentary: Emergence of nephrocardiology: Integrating management of cardiovascular and kidney diseases for holistic patient care
2024 · Mikhail S. Dzeshka, Alena Shantsila, et al. · Trends in Cardiovascular Medicine · 1
A Clinical Case of Successful 120-day Complex Treatment of Infectious Endocarditis of Mitral Valve With Mixomatous Degeneration Complicated by Cardiogenic and Septic Shock With Multiple Organ Failure
2024 · R. E. Yakubtsevich, M. S. Dzeshka, et al. · Journal of the Grodno State Medical University · 1
PDF
Works count: 48
Citation count: 1,095
H-index: 11
I10-index: 13
Year
Topic
Type